InfraScan, founded in Philadelphia, develops and markets handheld infrared imaging systems designed for the detection of hematomas and brain bleeding in head trauma patients. Their core mission is to provide rapid, non-invasive diagnostic tools to improve outcomes in emergency and military medical settings. InfraScan's flagship product, the FDA-cleared Infrascanner, is used globally in various applications, including neuro-ICU teams and military battalion aid stations.
Notable individuals affiliated with InfraScan include a distinguished management team and a scientific advisory board composed of experts in medical imaging and neurology. The company has achieved significant milestones, such as the deployment of over 200 Infrascanners to U.S. Marine Corps battalion aid stations. InfraScan's impact is evident in its contribution to enhancing trauma care and potentially saving lives through early detection of brain injuries.
